Loading...
OTCM
NUGL
Market cap1mUSD
Jul 09, Last price  
0.00USD
1D
7.69%
1Q
-17.65%
IPO
-99.67%
Name

NUGL Inc

Chart & Performance

D1W1MN
OTCM:NUGL chart
P/E
—
P/S
0.34
EPS
—
Div Yield, %
—
Shrs. gr., 5y
85.41%
Rev. gr., 5y
94.87%
Revenues
3m
+16.17%
149,451305,90831,76500000000072,482410,625122,8861,778,0002,229,0002,333,0002,973,0003,453,637
Net income
-48k
L-77.17%
-564,000-2,319,000-945,180-175,718-433,000315,526-100,95600-43,428-11,234-15,131-528,000-721,000-401,451-752,000-2,664,000-829,000-212,000-48,396
CFO
213k
P
-357,599-499,722-969,640-247,796-31,942-48,774-3,800-122,780000800-510,896-689,560-98,393-185,932-12,125245,991-546212,650

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

NUGL Inc. operates as a fully integrated medical cannabis business. The company manages cultivation and processing facilities, along with three retail dispensaries. Additionally, it holds various conditional licenses and distributes medical cannabis products for supply and export across regions including the Caribbean, Australia, and South America. Founded in 2018, NUGL Inc. is headquartered in Kingston, Jamaica.
URL
https://www.nugl.com/
IPO date
Oct 01, 2002
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT